News
Pfizer Inc. (NYSE:PFE) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider of Goldman ...
While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their ...
Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing ...
Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...
Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...
Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...
Explore more
Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than ...
Science came to life as curious young minds took center stage at the Pfizer School of Science Mobile Experience, a hands-on ...
Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Meningiomas are slow-growing tumors that are usually benign but can cause severe injury or death if they become large enough ...
Its dividend: The stock recently yielded a whopping 7.3%. That's hard to beat and will generate around $730 for every $10,000 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results